Inventiva S.A.
Inventiva S.A. (IVEVF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IVEVF · as of Jun 8, 2026
Key Statistics
Explore Inventiva S.A. Data
ivevf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 75.0%
Competitors & Peers
ivevf competitorsIVEVF
AIHLF
AMGXF
CCHWF
CKDXF
CLAZFStock Performance
Full HistoryAbout Inventiva S.A.
Inventiva S.A. a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses…
what is inventiva s.a. · ivevf stock overview · inventiva s.a. company profile · who is inventiva s.a. ceo · ivevf OTC · inventiva s.a. headquarters · inventiva s.a. business segments
About Stock Overview & Key Data
Inventiva S.A. (IVEVF) is a Healthcare company in the Biotechnology industry, listed on OTC since May 7, 2019. As of the latest trading session, IVEVF stock price is $4.00, with a market capitalization of $556.2M. The stock has returned +75.44% over the past 12 months and -9.91% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Inventiva S.A. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Inventiva S.A. reported revenue of $4.5M and net income of -$354.0M. For detailed data — including Inventiva S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Inventiva S.A. (IVEVF) stock price is $4.00. The stock is traded on OTC under the ticker symbol IVEVF. The 52-week range is $2.28 – $5.75.